Wedemeyer Wedemeyer H H Schoneweis Schoneweis K K Bogomolov Bogomolov PO PO Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in combination with PEG-interferon alpha 2a in patients with chronic HBV/HDV co-infection Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in combination with PEG-interferon alpha 2a in patients with chronic HBV/HDV co-infection J Hepatol J Hepatol 2019 2019 70 70 E81 E81 10.1016/S0618-8278(19)30141-0 10.1016/S0618-8278(19)30141-0. The gene discussed is IFNA2; the disease is coinfection.